BGLC Stock — BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp Common stock (BGLC)

Updated October 16, 2026.

BGLC is a Stock. Total return is -70.7% over the past 6.1 years, 215.9 points behind SPY at 145.2%.

BioNexus Gene Lab Corp. is a Malaysia-based company that trades industrial chemicals—including polyester resins used in automotive, marine, and aerospace applications—across Southeast Asia, and also provides genomic screening services and holds investments. The company's distribution profile is not currently known. This business may appeal to investors seeking exposure to industrial chemicals and emerging biotech screening services in Southeast Asian markets.

BGLC performance versus SPY

Price and return data through 2026-10-16.

Total return is -70.7% over the past 6.1 years, 215.9 points behind SPY at 145.2%. Over the past year its total return — price change plus distributions reinvested — is -76.7%. Its deepest 1-year drawdown was 78.1%.

BGLC key facts

Asset type

Stock

Asset class

Equity

Inception date

09/16/2020

Distribution frequency

None

Last close

$1.20 (as of 2026-10-16)

Market cap

$3,523,357

Average volume

6980.0

Beta

2.198

Payout ratio

0.0%

EPS

$-1.27

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

BGLC risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 78.1%.

Who may consider BGLC — and who may not

It is a weaker fit for investors who need monthly cash flow (BGLC does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on BGLC

• All tickers starting with B

Tagged: Materials.

Frequently asked questions